Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Study To Evaluate The Effects Of DP-b99 On Neurologic Function And Disability In Subjects With Acute Ischemic Hemispheric Stroke.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs DP b99 (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors D-Pharm
- 30 Aug 2006 Status change
- 17 Dec 2005 New trial record.